Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Identifying a therapeutic window of opportunity for people living with primary sclerosing cholangitis: Embryology and the overlap of inflammatory bowel disease with immune-mediated liver injury.

Autor: Kellermayer R; Division of Pediatric Gastroenterology, Department of Pediatrics, Texas Children's Hospital; Baylor College of Medicine, Houston, Texas, USA.; USDA/ARS Children's Nutrition Research Center (CNRC), Houston, Texas, USA., Carbone M; Centre for Autoimmune Liver Diseases, School of Medicine and Surgery, University of Milano-Bicocca, Milano, Italy.; Liver Unit, ASST Grande Ospedale Metropolitano Niguarda, Milano, Italy., Horvath TD; Department of Pathology and Immunology, Baylor College of Medicine, Houston, Texas, USA.; Department of Pathology, Texas Children's Hospital, Houston, Texas, USA., Szigeti RG; Department of Pathology and Genomic Medicine, Houston Methodist Hospital, Houston, Texas, USA., Buness C; Global Liver Institute Pediatric and Rare Liver Diseases Research Council, Washington DC, USA.; Autoimmune Liver Disease Network for Kids (A-LiNK), Stanford University, Stanford, CA, USA.; National Patient Advocate Foundation, Washington DC, USA., Hirschfield GM; Department of Medicine, Toronto Centre for Liver Disease, University of Toronto, Toronto, Canada., Lewindon PJ; Queensland Children's Hospital, Brisbane, QLD, Australia University of Queensland, Brisbane, QLD, Australia.

Publikováno v: Hepatology (Baltimore, Md.) [Hepatology] 2024 May 14. Date of Electronic Publication: 2024 May 14.